Statistics for Astria Therapeutics, (id:6608 ATXS)

Valuation metrics

Market cap

544.59M

Enterprise value

296.72M

Trailing P/E (ttm)

-3.99

Forward P/E

-5.45

PEG ratio

-5.45

Price/Sales (ttm)

Price/Book (mrq)

2.27

Enterprise Value/Revenue

Enterprise Value/EBITDA

-5.64

Overview

Shares outstanding

56.43M

Float

32.04M

Shares short

3.54M

% Held by insiders

0.00%

% Held by institutions

1.02%

Average volume (10 days)

270.71K

Average volume (90 days)

Price summary

52-Week low

4.43

52-Week high

16.90

52-Week change

51.19%

Beta

0.71

50-Day moving average

11.28

200-Day moving average

11.29

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

December 31th, 2018

Ex-dividend date

Last split factor

2:1

Last split date

August 20th, 2021

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-22.72%

Return on equity

-38.03%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

0.00

Net income to common (ttm)

-100,044,000.00

Diluted EPS (ttm)

-2.18

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

344.28M

Total cash per share (mrq)

5.95

Total debt (mrq)

5.64M

Total Debt/Equity (mrq)

1.65

Current ratio (mrq)

2.24K%

Book value per share (mrq)

4.26

Cash flow

Cash flow statement

-94,088,000.00

Levered free cash flow (LFCF)

-56,598,376.00